The FDA has approved the drug lecanemab for people with early Alzheimer's disease. USA TODAY health reporter kalltucker discusses the development with 5 Things podcast host atltwil:
Get the latest news, sports, entertainment, money and tech stories from USA TODAY through your voice.
Get the latest news, sports, entertainment, money and tech stories from USA TODAY through your voiceArgentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA approves use of Leqembi to treat Alzheimer's patientsFDA approves use of Leqembi Alzheimer\u0027s patients
Leer más »
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drugLeqembi is the first Alzheimer's antibody treatment to receive full FDA approval.
Leer más »
FDA to grant full approval for Alzheimer's medication LecanemabIf the FDA grants Lecanemab full approval, medical experts say Medicaid and Medicare will likely cover it MORE ⬇️
Leer más »
FDA to decide on Alzheimer’s drug approvalFull approval would likely prompt the Centers for Medicare and Medicaid Services to change how it covers the drug, broadening access for up to about a million people with early onset Alzheimer’s.
Leer más »
FDA to decide on Alzheimer’s drug approvalFull approval would likely prompt the Centers for Medicare and Medicaid Services to change how it covers the drug, broadening access for up to about a million people with early onset Alzheimer’s.
Leer más »
FDA to make a decision on whether to approve first Alzheimer’s drugThe FDA is set to decide whether it will fully approve the first Alzheimer’s drug to show it could slow the disease’s progression in certain patients. But the decision could also have other implications, including who would get access to it.
Leer más »